Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  methylmercaptopurine riboside
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-7 of 7 for your search:
Start Over
Phase II Study of 5-FU/MMPR/PALA in Unresectable Adenocarcinoma of the Pancreas (Summary Last Modified 08/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FCCC-91006, NCI-T91-0037D, T91-0037
Phase I Study with 6-Methylmercaptopurine Riboside/5-Fluorouracil by Continuous Infusion for Carcinoma, Sarcoma, and Leukemia
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-W82-0478, DFCI-81044
Phase I Clinical and Pharmacologic Study of MMPR, PALA, and 5-FU in Patients with Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-W81-0256
Phase I Combination Chemotherapy with PALA/MMPR/5-FU in Patients with Carcinoma and Sarcoma (Summary Last Modified 06/97)
Phase: Phase I
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: DFCI-82114, NCI-T83-0929D, T83-0929
Phase I Combination Chemotherapy with MMPR/PALA/5-FU in Patients with Advanced Cancer (Summary Last Modified 06/97)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-87121, NCI-T87-0259C, T87-0259
Phase I Study of PALA/MMPR/5-FU in Patients with Advanced Solid Tumors
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FCCC-88967, NCI-T88-0105D, T88-0105
Phase I Study of 5-FU with PALA/MMPR/CF in Patients with Advanced Malignancies (Summary Last Modified 01/92)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FCCC-91056, NCI-T91-0165D, T91-0165
Start Over